Cargando…

Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?

Preclinical investigation and clinical experience have provided evidence on the potential anticancer effect of artemisinin and its derivatives (ARTs) in the recent two decades. The major mechanisms of action of ARTs may be due to toxic-free radicals generated by an endoperoxide moiety, cell cycle ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhe, Li, Qin, Wu, Jun, Wang, Manyuan, Yu, Junxian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272993/ https://www.ncbi.nlm.nih.gov/pubmed/27739410 http://dx.doi.org/10.3390/molecules21101331

Ejemplares similares

Improving our forecasts for trachoma elimination: What else do we need to know?
por: Pinsent, Amy, et al.
Publicado: (2017)

What else can we do to prevent diabetic retinopathy?
por: Simó, Rafael, et al.
Publicado: (2023)

Unrecognized and Undertreated Vertebral Fractures: What Else We Must Do
por: Rao, Sudhaker D
Publicado: (2023)

Circadian Rhythms in Legumes: What Do We Know and What Else Should We Explore?
por: Kugan, Hazel Marie, et al.
Publicado: (2021)

Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
por: Pfab, Christina, et al.
Publicado: (2021)

What else can we do to mitigate contamination of fresh produce by foodborne pathogens?
por: Sela (Saldinger), Shlomo, et al.
Publicado: (2015)

Artemisinin derivative-containing therapies and abnormal hemoglobin: Do we need to adapt the treatment?
por: Gbessi, Eric A., et al.
Publicado: (2021)

Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?
por: Ma, Zhaowu, et al.
Publicado: (2021)

Olfaction and COVID: The little we Know and what else we need to know
por: Pinna, Fábio de Rezende, et al.
Publicado: (2020)

What else did we learn?
por: Pojer, M
Publicado: (2009)

Veteran homelessness in Australia: What do we know? What has been done? What do we need to do?
por: Wallace, Duncan, et al.
Publicado: (2023)

Drugs for malaria elimination: what do we have now and what do we need?
por: Shanks, Dennis
Publicado: (2014)

Evolutionary ecology of Chagas disease; what do we know and what do we need?
por: Flores‐Ferrer, Alheli, et al.
Publicado: (2017)

Walking Attenuates Postprandial Glycemic Response: What Else Can We Do without Leaving Home or the Office?
por: Bellini, Alessio, et al.
Publicado: (2022)

Why do we Need Quality Articles, What are we Going to do With?
por: Mueen Ahmed, KK
Publicado: (2011)

Do we need contrast agents for EUS?
por: Saftoiu, Adrian, et al.
Publicado: (2020)

Monkeypox Outbreaks in Non-Endemic Countries: What Do We Know and What Do We Need?
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Transarterial Chemoembolization Combined With Tyrosine Kinase Inhibitors for Intermediate‐Stage Hepatocellular Carcinoma, What Else Can We Do?
por: Deng, Jun, et al.
Publicado: (2022)

What Do We Need to Do for Better Casualty Support in Disasters?
por: Nekooei Moghadam, M, et al.
Publicado: (2011)

Pathogen Lists Do Not Tell Us What We Need to Do
por: Fedson, David S.
Publicado: (2019)

“Is there anything else I can do for you?”
por: Schreyer, Leighton
Publicado: (2021)

Review of the reverse innovation series in globalization and health – where are we and what else is needed?
por: Harris, Matthew, et al.
Publicado: (2020)

Review of social networks of professionals in healthcare settings—where are we and what else is needed?
por: Hu, Huajie, et al.
Publicado: (2021)

Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020)

Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
por: Gershman, Boris, et al.
Publicado: (2015)

What else could we farm out to industry?
por: Gruber, J
Publicado: (1991)

Pathology of healing: what else might we look at?
por: Horimoto, Yoshiya, et al.
Publicado: (2016)

Familial Intracranial Aneurysms in Saudi Arabia: What Do We Need To Do?
por: Al-Jehani, Hosam, et al.
Publicado: (2016)

Why do we need agent-based macroeconomics?
por: Cincotti, Silvano, et al.
Publicado: (2022)

What do we need for \nu counting in DELPHI ?
por: Clara, M P, et al.
Publicado: (1991)

What do we need to understand and optimize the LHC?
por: Bruning, O S
Publicado: (2010)

Biosimilar therapeutics—what do we need to consider?
por: Schellekens, Huub
Publicado: (2009)

What is vitamin A and why do we need it?
por: Gilbert, Clare
Publicado: (2013)

Publication ethics – What do we need to know?
por: Mills, Michael
Publicado: (2019)

Acute kidney injury in critically ill newborns: What do we know? What do we need to learn?
por: Askenazi, David J., et al.
Publicado: (2009)

Equine Crofton Weed (Ageratina spp.) Pneumotoxicity: What Do We Know and What Do We Need to Know?
por: Shapter, Frances Marie, et al.
Publicado: (2023)

Discovery and repurposing of artemisinin
por: Shi, Qiaoli, et al.
Publicado: (2022)

Cataract surgery – Where are we today and what do we need?
por: Heda, Aarti, et al.
Publicado: (2022)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_68b6nmkg1af34ppr8je6n0bdnh